Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7738142

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2012-04-01 to
2013-03-31
As at
2013-03-31
As at
2013-03-31
2012-04-01 to
2013-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
99,949,000,000 JPY
101,479,000,000 JPY
107,627,000,000 JPY
109,730,000,000 JPY
91,951,000,000 JPY
93,889,000,000 JPY
87,101,000,000 JPY
88,946,000,000 JPY
87,054,000,000 JPY
85,270,000,000 JPY
Ordinary profit (loss)
30,863,000,000 JPY
30,981,000,000 JPY
34,743,000,000 JPY
35,365,000,000 JPY
19,845,000,000 JPY
20,394,000,000 JPY
14,957,000,000 JPY
15,521,000,000 JPY
14,250,000,000 JPY
13,656,000,000 JPY
Profit (loss)
21,940,000,000 JPY
18,757,000,000 JPY
11,777,000,000 JPY
9,395,000,000 JPY
8,634,000,000 JPY
Share capital
23,853,000,000 JPY
23,853,000,000 JPY
23,853,000,000 JPY
23,853,000,000 JPY
23,853,000,000 JPY
Total number of issued shares
48,439,000 xbrli:shares
48,439,000 xbrli:shares
96,879,000 xbrli:shares
101,879,000 xbrli:shares
101,879,000 xbrli:shares
Net assets
102,655,000,000 JPY
103,424,000,000 JPY
91,103,000,000 JPY
89,875,000,000 JPY
79,069,000,000 JPY
77,100,000,000 JPY
68,096,000,000 JPY
71,816,000,000 JPY
68,761,000,000 JPY
66,578,000,000 JPY
Total assets
135,060,000,000 JPY
133,157,000,000 JPY
130,838,000,000 JPY
132,991,000,000 JPY
115,834,000,000 JPY
115,135,000,000 JPY
106,465,000,000 JPY
106,529,000,000 JPY
110,483,000,000 JPY
108,911,000,000 JPY
Net assets per share
2,511.68
2,530.50
2,200.25
2,170.60
1,908.66
1,861.12
1,611.78
1,699.82
1,592.76
1,542.20
Dividend paid per share
150.00
112.00
59.00
48.00
44.00
Interim dividend paid per share
75.00
34.00
27.00
24.00
22.00
Basic earnings (loss) per share
534.84
536.70
452.92
510.54
282.61
290.90
220.30
228.27
206.61
198.39
Diluted earnings per share
Equity-to-asset ratio
0.760 xbrli:pure
0.777 xbrli:pure
0.696 xbrli:pure
0.676 xbrli:pure
0.683 xbrli:pure
0.670 xbrli:pure
0.640 xbrli:pure
0.674 xbrli:pure
0.622 xbrli:pure
0.611 xbrli:pure
Rate of return on equity
0.226 xbrli:pure
0.229 xbrli:pure
0.220 xbrli:pure
0.253 xbrli:pure
0.156 xbrli:pure
0.167 xbrli:pure
0.134 xbrli:pure
0.145 xbrli:pure
0.140 xbrli:pure
0.129 xbrli:pure
Price-earnings ratio
11.8 xbrli:pure
11.7 xbrli:pure
15.0 xbrli:pure
13.3 xbrli:pure
24.6 xbrli:pure
23.9 xbrli:pure
14.8 xbrli:pure
14.3 xbrli:pure
16.7 xbrli:pure
17.4 xbrli:pure
Payout ratio
0.280 xbrli:pure
0.322 xbrli:pure
0.418 xbrli:pure
0.436 xbrli:pure
0.444 xbrli:pure
Net cash provided by (used in) operating activities
15,327,000,000 JPY
27,067,000,000 JPY
14,737,000,000 JPY
13,663,000,000 JPY
11,729,000,000 JPY
Net cash provided by (used in) investing activities
-3,503,000,000 JPY
-4,105,000,000 JPY
473,000,000 JPY
-2,135,000,000 JPY
-6,792,000,000 JPY
Net cash provided by (used in) financing activities
-9,800,000,000 JPY
-5,984,000,000 JPY
-7,900,000,000 JPY
-10,992,000,000 JPY
-5,867,000,000 JPY
Cash and cash equivalents
43,767,000,000 JPY
41,744,000,000 JPY
24,767,000,000 JPY
17,457,000,000 JPY
16,920,000,000 JPY
Number of employees
1,405 xbrli:pure
1,398 xbrli:pure
1,444 xbrli:pure
1,451 xbrli:pure
1,493 xbrli:pure
1,503 xbrli:pure
1,540 xbrli:pure
1,523 xbrli:pure
1,649 xbrli:pure
1,666 xbrli:pure
Average number of temporary employees
298 xbrli:pure
294 xbrli:pure
306 xbrli:pure
309 xbrli:pure
301 xbrli:pure
304 xbrli:pure
293 xbrli:pure
289 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.